mi-134 Modulates the Proliferation of Human Cardiomyocyte Progenitor Cells by Targeting Meis2.

Cardiomyocyte progenitor cells play essential roles in early heart development, which requires highly controlled cellular organization. microRNAs (miRs) are involved in various cell behaviors by post-transcriptional regulation of target genes. However, the roles of miRNAs in human cardiomyocyte progenitor cells (hCMPCs) remain to be elucidated. Our previous study showed that mi-134 was significantly downregulated in heart tissue suffering from congenital heart disease, underlying the potential role of mi-134 in cardiogenesis. In the present work, we showed that the upregulation of mi-134 reduced the proliferation of hCMPCs, as determined by EdU assay and Ki-67 immunostaining, while the inhibition of mi-134 exhibited an opposite effect. Both up- and downregulation of mi-134 expression altered the transcriptional level of cell-cycle genes. We identified Meis2 as the target of mi-134 in the regulation of hCMPC proliferation through bioinformatic prediction, luciferase reporter assay and western blot. The over-expression of Meis2 mitigated the effect of mi-134 on hCMPC proliferation. Moreover, mi-134 did not change the degree of hCMPC differentiation into cardiomyocytes in our model, suggesting that mi-134 is not required in this process. These findings reveal an essential role for mi-134 in cardiomyocyte progenitor cell biology and provide new insights into the physiology and pathology of cardiogenesis. [ABSTRACT FROM AUTHOR]